首页 | 本学科首页   官方微博 | 高级检索  
   检索      


New tumor suppressor CXXC finger protein 4 inactivates mitogen activated protein kinase signaling
Authors:Haiqi Lu  Wei Jin  Jie Sun  Lifeng Feng  Huiyin Lan  Qi Shen  Yanning Ma  Jiaqiu Li  Yongfang Yue  Hongchuan Jin  Xian Wang
Institution:1. Department of Medical Oncology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China;2. Laboratory of Cancer Biology, Institute of Clinical Science, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
Abstract:As a well-characterized master player in epigenetic regulatory network, EZH2 is widely implicated in the development of many malignancies. We previously found that EZH2 promoted Wnt/β-catenin activation through downregulation of CXXC4 expression. In this report, we demonstrated that CXXC4 inhibited MAPK signaling through binding to ERK-1/2 and abrogating the interaction of ERK 1/2 with MEK1/2. L183, the critical residue in CXXC4 ERK D domain, was found to be essential for CXXC4–ERK 1/2 interaction and the growth inhibitory effect of CXXC4 in human cancer cells. In summary, CXXC4 directly disrupted MEK1/2–ERK 1/2 interaction to inactivate MAPK signaling. L183 site is indispensable for the binding of CXXC4 to ERK1/2 and growth inhibitory effect of CXXC4. Therefore, EZH2 can activate MAPK signaling by inhibiting CXXC4 expression.
Keywords:Enhancer of zeste homologue 2 (EZH2)  CXXC finger protein 4 (CXXC4)  Mitogen-activated protein kinase (MAPK)  Extracellular signal-regulated kinase (ERK)  MAP kinase (MEK)  Gastric carcinogenesis
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号